New Developments in Plasma Proteomics
A single protein or gene expression product can exist in multiple proteoforms due to alternative splicing, point mutations, post translational modifications and endogenous proteolysis.
Exploring the Optimization of Linker Chemistries for ADCs
A look at how linker technology for antibody drug conjugates has evolved.
AbbVie Collaborates with BigHat Biosciences on Next-Gen Therapeutic Antibodies
This collaboration will combine BigHat Biosciences’ AI/ML-guided Milliner platform with AbbVie's expertise in oncology and neuroscience to develop next-generation antibodies.
Absci and AstraZeneca Collaborate on AI-Driven Oncology Candidate
AstraZeneca will utilize Absci’s AI antibody drug creation platform to create an AI-designed antibody.
New Medicines, Markets, and Manufacture: CRISPR for Sickle Cell Disease and β-thalassemia
Exagamglogene autotemcel seen as synechdoche.
TAU Systems to Establish TAU Labs, a New Laser Plasma Accelerator Application Center
TAU Systems plans to establish TAU Labs, a new next-generation, laser-driven plasma accelerator laboratory, in Carlsbad, Calif.
Genentech and NVIDIA Form AI Research Collaboration for Drug Discovery and Development
Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.
MilliporeSigma Expands Biologics Testing Center in China
MilliporeSigma has expanded its biosafety testing laboratories in Shanghai, China, with the completion of new lab space at its new €29 million (US$43 million) Biologics Testing Center.
Twist Bioscience Launches Gene Synthesis Service
Twist Bioscience now offers its Express Genes rapid gene synthesis service at its Wilsonville, Ore., manufacturing facility.
Lonza Launches New Cell Line for Higher Potency Antibody Development
Lonza’s new GS Effex cell line can help overcome the challenges of developing therapeutic antibodies with increased potency.
